Evidence map›Paper›PMID 42416589›Full record

ReviewReviews in cardiovascular medicine2026

Clinical Updates in Pulmonary Hypertension.

Gabriela Diaz, Alyssa Lawrence, Julia Ossi, Dirichi Arungwa, Allison Weiss, Hafeez Ul Hassan Virk, Muzamil Khawaja, Chayakrit Krittanawong

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gabriela DiazDepartment of Internal Medicine, Emory University, Atlanta, GA 30322, USA.ORCID https://orcid.org/0000-0002-1115-9098
Alyssa LawrenceDepartment of Internal Medicine, Emory University, Atlanta, GA 30322, USA.
Julia OssiDepartment of Internal Medicine, Emory University, Atlanta, GA 30322, USA.
Dirichi ArungwaDepartment of Internal Medicine, Emory University, Atlanta, GA 30322, USA.
Allison WeissDepartment of Internal Medicine, Emory University, Atlanta, GA 30322, USA.
Hafeez Ul Hassan VirkDivision of Cardiovascular Disease, Department of Medicine, Albert Einstein Healthcare Network, Philadelphia, PA 19141, USA.
Muzamil KhawajaDepartment of Cardiology, Emory University, Atlanta, GA 30322, USA.
Chayakrit KrittanawongHumanX, Delaware, DE 19801, USA.ORCID https://orcid.org/0000-0001-7953-335X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension is a heterogeneous, progressive condition affecting pulmonary vasculature. Epidemiologic studies have highlighted underdiagnosis and persistent disparities in access to expert care, treatments, and outcomes. Biomarkers and imaging‑based phenotyping are enhancing early detection, while emerging technologies for monitoring and novel treatment targets show promise for a new horizon in individualized management of pulmonary hypertension. This review aims to summarize the epidemiology, pathogenesis, definitions, treatment, and future directions of pulmonary hypertension.

Indexed as

PAHPHpulmonary hypertension

Identifiers

PMID42416589
PMCPMC13339242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.